|
|
|
|
|
Bupropion Hydrochloride |
|
C13H18ClNO•HCl |
|
31677-93-7 |
|
Bupropion is an indirect dopaminergic agonist, developed by GlaxoSmithKline as an antidepressant. It may also have potential in obesity, and post-traumatic stress. A sustained-release formulation (bupropion SR qv) is launched for the treatment of depression and as an aid to smoking cessation. |
|
USP24 |
Á¦Ç°°ü·ÃºÐ¾ß |
ÈÀåÇ°, ÀǾà,Áß°£Ã¼ |
|
|
|
|
|
|
|
ÀÌÁ¦Ç°¿¡ ´ëÇØ µî·ÏµÈ ÆǸž÷ü°¡ ¾ø½À´Ï´Ù. |
|
|
|
|
|